London School of Hygiene and Tropical Medicine
π§πͺBelgium
- Country
- π§πͺBelgium
- Ownership
- Private
- Established
- 1899-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.lshtm.ac.uk
Prevention of Severe Anaemia in Gambian Children
Phase 3
Completed
- Conditions
- Anemia
- First Posted Date
- 2005-08-19
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 1200
- Registration Number
- NCT00131716
- Locations
- π¬π²
Medical Research Council Laboratories,, Banjul, Gambia
Bacillus Calmette-Guerin (BCG) Vaccine and Morbidity From Malaria
Phase 3
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-08-19
- Last Posted Date
- 2016-09-02
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 1200
- Registration Number
- NCT00131794
- Locations
- π¬πΌ
Bandim Health Project, Bissau, Guinea-Bissau
Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines
Phase 1
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 120
- Registration Number
- NCT00121823
- Locations
- π¬π²
Medical Research Council Laboratories, Banjul, Gambia
Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian Men
Phase 1
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 32
- Registration Number
- NCT00121771
- Locations
- π¬π²
Medical Research Council Laboratories, Banjul, Gambia
Folic Acid Supplementation in Gambian Primigravidae
Phase 3
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-07-19
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 1000
- Registration Number
- NCT00120822
- Locations
- π¬π²
Medical Research Council, Laboratories, Banjul, Gambia
Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae
Phase 3
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-07-19
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 3000
- Registration Number
- NCT00120809
- Locations
- π¬π²
Medical Research Council Laboratories, Banjul, Gambia
Kintampo Trial of Combination Therapy for Malaria
Phase 4
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-07-13
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 510
- Registration Number
- NCT00119145
- Locations
- π¬π
Kintampo Health Research Centre, Kintampo, Brong Ahafo Region, Ghana
Effectiveness of Intermittent Preventive Treatment for Malaria in Children
Phase 2
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-07-13
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 2602
- Registration Number
- NCT00119132
- Locations
- π¬π
Ministry of Health, Hohoe district hospital, Hohoe, Volta region, Ghana
Lapdap and Coartemether for Uncomplicated Malaria
Phase 3
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-07-12
- Last Posted Date
- 2006-02-01
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 1200
- Registration Number
- NCT00118794
- Locations
- π¬π²
Medical Research Council Laboratories, Banjul, Gambia
Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children
Phase 3
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-07-12
- Last Posted Date
- 2006-01-09
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 1800
- Registration Number
- NCT00118807
- Locations
- π¬π²
Medical Research Council Laboratories, Banjul, Gambia
Β© Copyright 2025. All Rights Reserved by MedPath